Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations

被引：8
作者：
Franco, Luciana F. [1 ]
Szarf, Gilberto [2 ]
Dotto, Renata P. [1 ]
Dib, Sergio A. [1 ]
Moises, Regina S. [1 ]
Giuffrida, Fernando M. A. [1 ,3 ]
Reis, Andre F. [1 ]
机构：
[1] Univ Fed Sao Paulo UNIFESP, Disciplina Endocrinol, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo UNIFESP, Dept Diagnost Imagem, Sao Paulo, Brazil
[3] Univ Estado Bahia UNEB, Dept Ciencias Vida, Salvador, BA, Brazil
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2021年 / 176卷
基金：
巴西圣保罗研究基金会;
关键词：
Glucokinase; Monogenic diabetes; MODY; Coronary artery disease; Coronary artery calcium; COMPUTED-TOMOGRAPHY; DISEASE; ASSOCIATION; APPRAISAL; DETECTOR; MODY-2; GENE; GCK;
D O I：
10.1016/j.diabres.2021.108867
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aims: Maturity- Onset Diabetes of the Young (MODY) caused by glucokinase (GCK) mutations is characterized by lifelong mild non-progressive hyperglycemia, with low frequency of coronary artery disease (CAD) compared to other types of diabetes. The aim of this study is to estimate cardiovascular risk by coronary artery calcification (CAC) score in this group. Materials and methods: Twenty-nine GCK-MODY cases, 26 normoglycemic controls (recruited among non-affected relatives/spouses of GCK mutation carriers), and 24 unrelated individuals with type 2 diabetes were studied. Patients underwent CAC score evaluation by computed tomography and were classified by Agatston score >= or < 10. Framingham Risk scores of CAD in 10 years were calculated. Results: Median [interquartile range] CAC score in GCK-MODY was 0 [0,0], similar to controls (0 [0,0], P = 0.49), but lower than type 2 diabetes (39 [0, 126], P = 2.6 x 10(-5)). A CAC score >= 10 was seen in 6.9% of the GCK group, 7.7% of Controls (P = 1.0), and 54.2% of individuals with type 2 diabetes (P = 0.0006). Median Framingham risk score was lower in GCK than type 2 diabetes (3% vs. 13%, P = 4 x 10(-6)), but similar to controls (3% vs. 4%, P = 0.66). Conclusions: CAC score in GCK-MODY is similar to control individuals from the same family and/or household and is significantly lower than type 2 diabetes. Besides demonstrating low risk of CAD in GCK-MODY, these findings may contribute to understanding the specific effect of hyperglycemia in CAD. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数：11
相关论文
共 43 条
[1]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[2]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[3]   Phenotypic heterogeneity in monogenic diabetes: The clinical and diagnostic utility of a gene panel-based next-generation sequencing approach [J].
Alkorta-Aranburu, G. ;
Carmody, D. ;
Cheng, Y. W. ;
Nelakuditi, V. ;
Ma, L. ;
Dickens, Jazzmyne T. ;
Das, S. ;
Greeley, S. A. W. ;
del Gaudio, D. .
MOLECULAR GENETICS AND METABOLISM, 2014, 113 (04) :315-320
[4]   Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020 [J].
不详 .
DIABETES CARE, 2020, 43 :S14-S31
[5]   Coronary artery calcium measurement: Agreement of multirow detector and electron beam CP [J].
Becker, CR ;
Kleffel, T ;
Crispin, A ;
Knez, A ;
Young, J ;
Schoepf, UJ ;
Haberl, R ;
Reiser, MF .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001, 176 (05) :1295-1298
[6]   Assessment of coronary artery disease by cardiac computed tomography - A scientific statement from the American Heart Association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology [J].
Budoff, Matthew J. ;
Achenbach, Stephan ;
Blumenthal, Roger S. ;
Carr, J. Jeffrey ;
Goldin, Jonathan G. ;
Greenland, Philip ;
Guerci, Alan D. ;
Lima, Joao A. C. ;
Rader, Daniel J. ;
Rubin, Geoffrey D. ;
Shaw, Leslee J. ;
Wiegers, Susan E. .
CIRCULATION, 2006, 114 (16) :1761-1791
[7]   Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation [J].
Challis, Benjamin G. ;
Harris, Julie ;
Sleigh, Alison ;
Isaac, Iona ;
Orme, Steve M. ;
Seevaratnam, Nandini ;
Dhatariya, Ketan ;
Simpson, Helen L. ;
Semple, Robert K. .
CLINICAL ENDOCRINOLOGY, 2014, 81 (06) :855-861
[8]   Primary and subsequent coronary risk appraisal: New results from The Framingham Study [J].
D'Agostino, RB ;
Russell, MW ;
Huse, DM ;
Ellison, RC ;
Silbershatz, H ;
Wilson, PWF ;
Hartz, SC .
AMERICAN HEART JOURNAL, 2000, 139 (02) :272-281
[9]   Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans [J].
De Ceuninck, Frederic ;
Kargar, Catherine ;
Ilic, Catherine ;
Caliez, Audrey ;
Rolin, Jean-Olivier ;
Umbdenstock, Thierry ;
Vinson, Cedric ;
Combettes, Murielle ;
de Fanti, Brant ;
Harley, Elizabeth ;
Sadlo, Marjorie ;
Lefevre, Anne-Laure ;
Broux, Olivier ;
Wierzbicki, Michel ;
Fourquez, Jean-Marie ;
Perron-Sierra, Francoise ;
Kotschy, Andras ;
Ktorza, Alain .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (02) :339-353
[10]   Nitric oxide system and diabetic nephropathy [J].
Dellamea, Bruno Schmidt ;
Leitao, Cristiane Bauermann ;
Friedman, Rogerio ;
Canani, Luis Henrique .
DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
12345